In a healthcare industry that has become inundated with physicians who overprescribe pain medication and are all too eager to ...

The U.S. Food and Drug Administration (FDA) created a major media stir last week when it announced the approval of suzetrigine (brand name Journavx), a unique new non-opioid, non-addictive drug for ...